Literature DB >> 16926975

Association between angiotensin-converting enzyme gene polymorphism and childhood allergic rhinitis in Taiwan.

Min-Sho Ku1, Ko-Huang Lue, Ching Li, Hai-Lun Sun, Ming-Chih Chou.   

Abstract

BACKGROUND AND
PURPOSE: Angiotensin-converting enzyme (ACE) play a role in inactivating bradykinin and tachykinins. Bradykinin and tachykinins are potent mediators of inflammatory reaction. An insertion/deletion polymorphism of the ACE gene has been shown to be associated with serum ACE levels. We hypothesized that ACE polymorphism might play a role in allergic rhinitis development.
METHODS: Seventy five children aged 6-13 years with atopic allergic rhinitis and 66 age- and gender-matched healthy children were studied. ACE genotypes were determined by polymerase chain reaction. Serum total immunoglobulin E (IgE) and allergen-specific IgE levels were also measured.
RESULTS: The frequencies of the DD and non-DD genotypes, and of the II and non-II genotypes did not differ significantly between healthy children and allergic rhinitis children (chi-squared test, p=1.000 and 0.438, respectively). There was no association of ACE genotype and mean IgE levels in rhinitis children or healthy controls.
CONCLUSION: The results of our study indicate that polymorphism of the ACE gene is unrelated to the development of allergic rhinitis, the duration of allergic rhinitis, serum IgE levels, and allergen-specific IgE in Taiwanese children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926975

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  1 in total

Review 1.  Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to allergic rhinitis in Chinese populations: a systematic review and meta-analysis.

Authors:  Ruo-Fei Huang; Pin Dong; Tian-Zhen Zhang; Xin-Jiang Ying; Hua Hu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-24       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.